Regulatory T cells and allergic asthma

Microbes and Infection

Volumn 3, Issue 11, 2001, Pages 899-904

  Yssel, Hans ^a   Lécart, Sandrine ^a   Pène, Jérôme ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Allergic asthma; T regulatory cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; BRONCHUS HYPERREACTIVITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EOSINOPHIL; HUMAN; IMMUNOTHERAPY; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY TRACT INFLAMMATION; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0034844838     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01450-2     Document Type: Review

References (48)

1. The role of allergy and atopy in asthma
2. Asthma genetics: Waiting to exhale
3. The biology of the eosinophilic leukocyte
4. Immunologic basis of antigen-induced airway hyperresponsiveness
5. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
6. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
7. Functional diversity of helper T lymphocytes
8. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
9. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
10. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a nonanaphylactogenic anti-IgE antibody
11. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma
12. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation
13. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
14. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice
15. Interleukin-10
16. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide
17. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils
18. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation
19. IL-10 and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II MHC expression
20. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells: Specific inhibition of IL-2 production and proliferation
21. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
22. CD40 expression by human peripheral blood eosinophils
23. Interleukin 10 protects mice from lethal endotoxemia
24. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT
25. Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: Role of endogenous IL-12
26. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice
27. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells
28. Interleukin-10 regulation in normal subjects and patients with asthma
29. T cells subsets and cytokines in allergic and non-allergic children. II. Analysis and IL-5 and IL-10 mRNA expression and protein production
30. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers
31. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus
32. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma
33. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma
34. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice
35. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction
36. IL-10 is necessary for the expression of airway hyperresponsiveness but not pulmonary inflammation after allergic sensitization
37. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis
38. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs
39. A CD4+ T-cell subset inhibits antigen-specific T cell responses and prevents colitis
40. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
41. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
42. Role of interleukin 10 in specific immunotherapy
43. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cells
44. IgE versus IgG4 production can be differentially regulated by IL-10
45. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation
46. Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases
47. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis